‘Belviq’ has rapidly become a leader

The power of an obesity treatment approved by the FDA was tremendous. Belviq, an obesity treatment first launched by Ildong Pharmaceutical on March, recorded KRW 6 billion sales in 4 months since its launch, rapidly becoming a leading product in the market.

In this market where there has been no blockbuster for a while since liquidation of sibutramine, Belviq guaranteed to become a product wor...